| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.790.678 | 4.231.462 | 4.714.554 | 5.798.866 | 6.390.443 | 7.253.162 | 7.217.318 | 11.807.430 | 17.551.782 | 17.056.159 |
| Total Income - EUR | 3.858.680 | 4.282.272 | 4.922.435 | 5.817.846 | 6.451.981 | 7.289.807 | 7.238.057 | 11.889.660 | 17.655.833 | 17.138.435 |
| Total Expenses - EUR | 3.655.182 | 4.150.281 | 4.679.357 | 5.563.733 | 6.284.073 | 6.977.441 | 7.223.200 | 11.694.059 | 17.939.115 | 16.662.811 |
| Gross Profit/Loss - EUR | 203.498 | 131.990 | 243.078 | 254.113 | 167.908 | 312.366 | 14.857 | 195.600 | -283.283 | 475.624 |
| Net Profit/Loss - EUR | 165.919 | 101.551 | 194.025 | 207.829 | 139.060 | 250.441 | -8.904 | 108.416 | -321.976 | 411.869 |
| Employees | 55 | 68 | 75 | 90 | 105 | 121 | 0 | 148 | 180 | 0 |
Check the financial reports for the company - Stada Hemofarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.897.281 | 3.520.515 | 3.163.240 | 2.846.103 | 2.714.494 | 3.103.417 | 3.059.822 | 3.451.291 | 5.919.897 | 6.507.643 |
| Current Assets | 530.200 | 654.898 | 1.076.558 | 1.448.820 | 2.160.458 | 2.281.080 | 2.614.783 | 3.870.340 | 4.965.401 | 2.382.164 |
| Inventories | 98.802 | 133.609 | 190.423 | 221.366 | 218.085 | 343.296 | 441.296 | 540.016 | 583.192 | 524.618 |
| Receivables | 272.000 | 248.460 | 524.053 | 997.573 | 1.679.161 | 1.459.215 | 1.955.623 | 3.204.001 | 4.141.164 | 1.550.057 |
| Cash | 159.399 | 272.830 | 362.082 | 229.881 | 263.212 | 478.569 | 217.864 | 126.323 | 241.045 | 307.489 |
| Shareholders Funds | 3.340.000 | 3.407.488 | 3.543.852 | 3.686.646 | 3.754.309 | 3.933.577 | 3.837.443 | 3.941.685 | 3.607.756 | 3.999.463 |
| Social Capital | 2.610.009 | 2.583.390 | 2.539.675 | 2.493.068 | 2.444.787 | 2.398.439 | 2.345.251 | 2.352.528 | 2.345.394 | 2.332.286 |
| Debts | 1.223.315 | 776.260 | 963.518 | 928.236 | 1.134.469 | 1.439.253 | 1.817.121 | 3.337.138 | 7.042.038 | 6.361.881 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 982.499 | 168.134 | 147.675 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
7120
|
|||||||||
Comments - Stada Hemofarm Srl